Skip to content

Released Aug 13, 2025, before the open

10-Q filed Aug 13, 2025, 44 days after period end · 0001789769-25-000081

Q2 2025 · 10-Q
Revenue—
Net Income-$21.39MN/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$3.24N/M vs Q2 2024N/M vs Q1 2025
Operating Income-$23,440,000N/M
Operating Cash Flowderived-$14,791,000N/M

What the release said

The release

Same quarter

MetricQ2 2025Q2 2024Q2 2023Q2 2022
Net Income-$21.39M-$14.92M-$18.66M-$58.99M
EPS Diluted-$3.24-$2.29-$2.87-$0.46

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR